Search results
A decades-old FDA rule is keeping Americans from having better sunscreen
NBC Universal via AOL· 1 day agoThe FDA's ability to approve the chemical filters in sunscreens that are sold in other countries is...
FDA approves Alecensa as leading-edge adjuvant therapy for ALK-positive lung cancer
Clinical Trials Arena via Yahoo Finance· 3 days agoUnlike Alecensa, Lorbrena lacks ongoing label expansion trials in adjuvant settings, placing it at a...
FDA misses own deadline to propose ban on cancer-linked formaldehyde from hair relaxers
TODAY via Yahoo News· 3 days agoThe FDA announced it would propose a ban on formaldehyde commonly found in hair relaxers typically...
Pfizer, Genmab Get Full FDA Approval for Cervical-Cancer Drug
Morningstar· 6 days agoPfizer and Genmab on Monday said they had received full approval from U.S. regulators for their treatment for certain forms of cervical cancer. The companies' drug Tivdak ...
FDA Releases Final Rule on Regulation of Laboratory-Developed Tests
GenomeWeb News· 6 days agoThe rule makes explicit that LDTs are in vitro diagnostics and as such are subject to oversight by...
US FDA grants full approval for Pfizer's cervical cancer drug
AOL· 6 days agoThe treatment, Tivdak - an antibody-drug conjugate co-developed by Genmab A/S and Seagen - received the FDA's accelerated approval for the same indication in 2021. It was ...
Is Your Cancer Test Accurate? The FDA Wants to Make Sure
The Wall Street Journal· 6 days ago“The final rule announced today aims to provide crucial oversight of these tests.” The rule is...
Chemo can be brutal. This FDA effort aims to make it less so.
Washington Post· 1 day agoThe FDA has begun requiring companies to pinpoint the right dosage before cancer drugs reach...
FDA issues final rule regulating LDTs as medical devices
Medical Device Network via Yahoo Finance· 5 days agoThe FDA ruling follows years of industry back and forth and sees the government body choosing to...
Cancer screenings, menthols and the moonshot
Politico· 3 days agoEven so: Advocates of improved cancer care aren’t thrilled with Biden right now. That’s because his administration last week delayed an FDA rule to ban...
